Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

PURE Insider Trading

PURE BIOSCIENCE, INC. | Miscellaneous Chemical Products

Comprehensive Trading Performance Summary

The investment history of corporate insiders at PURE BIOSCIENCE, INC. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Miscellaneous Chemical Products sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2023-03-23 00:55 2023-03-21 Blotner Bernard Director BUY $0.13 10,000 $1,299 10,000 +100.0%
2023-03-23 00:53 2023-03-22 BARTLETT ROBERT F Director, Officer - CEO BUY $0.16 50,000 $7,750 50,000 +100.0%
2022-12-20 02:48 2022-12-15 Lee Tom Y Director, Officer, 10% owner - Chief Executive Officer BUY $0.13 50,000 $6,550 5,001,843 +1.0%
2022-03-23 04:49 2022-03-16 Lee Tom Y Director, Officer, 10% owner - Chief Executive Officer BUY $0.20 219,477 $42,820 4,951,843 +4.6%
2021-06-23 03:24 2021-06-16 Lee Tom Y Director, Officer - Chief Executive Officer BUY $0.43 35,998 $15,515 4,732,366 +0.8%
2020-12-29 01:44 2020-12-16 Lee Tom Y Director, Officer - Chief Executive Officer BUY $0.66 78,721 $52,247 4,696,368 +1.7%
2020-06-23 03:58 2020-06-18 Lee Tom Y Director, Officer - Chief Executive Officer BUY $1.76 53,124 $93,573 4,617,647 +1.2%
2020-06-19 01:19 2020-06-12 Lee Tom Y Director, Officer - Chief Executive Officer BUY $1.74 202,033 $351,861 4,564,523 +4.6%
2020-02-11 02:54 2019-12-31 Okuno Dale Director SELL $0.29 788,880 $228,381 5,520,540 -12.5%
2020-02-11 02:51 2019-12-19 Lee Tom Y Director BUY $0.29 754,884 $218,161 22,891,070 +3.4%
2019-10-04 01:30 2019-10-02 Okuno Dale Director BUY $0.29 862,068 $250,000 6,309,420 +15.8%
2019-10-04 01:28 2019-10-02 Lee Tom Y Director BUY $0.29 1,000,000 $290,000 22,136,186 +4.7%
2019-06-26 00:30 2019-05-09 Okuno Dale Director BUY $0.29 862,068 $250,000 5,447,352 +18.8%
2019-06-26 00:21 2019-05-09 Chen Ivan Director BUY $0.29 120,689 $35,000 270,689 +80.5%
2019-05-14 01:04 2019-05-09 Okuno Dale Director BUY $0.35 714,285 $250,000 5,299,569 +15.6%
2019-05-14 01:03 2019-05-09 Chen Ivan Director BUY $0.35 100,000 $35,000 250,000 +66.7%
2018-08-21 02:10 2018-08-16 Lee Tom Y Director BUY $0.45 2,336,187 $1,051,284 21,002,853 +12.5%
2018-01-13 01:38 2018-01-10 Lambert Henry R. Director, Officer - Chief Executive Officer SELL $0.93 41,500 $38,549 498,056 -7.7%
2017-12-30 01:12 2017-12-29 Lee Tom Y Director BUY $0.00 18,666,666 $0 18,666,666 +100.0%
2017-12-30 01:11 2017-12-29 Franchise Brands, LLC 10% owner SELL $0.00 18,666,666 $0 0 -100.0%
2017-04-14 02:39 2017-04-11 Lambert Henry R. Director, Officer - Chief Executive Officer SELL $0.95 3,301 $3,136 339,556 -1.0%
2016-12-23 02:18 2016-12-21 Lee Tom Y Director SELL $0.95 14,885 $14,141 3,684,452 -0.4%
2016-06-14 03:14 2015-10-23 Franchise Brands, LLC 10% owner BUY $0.45 13,333,333 $6,000,000 18,666,666 +250.0%
2015-09-10 00:10 2014-07-18 THENO DAVID M Director BUY $0.75 34,000 $25,500 234,000 +17.0%
2015-09-10 00:08 2014-07-02 Pfanzelter David J Director BUY $0.75 40,000 $30,000 2,840,000 +1.4%
2015-09-10 00:06 2014-08-01 Otis William Director BUY $0.75 22,666 $17,000 222,666 +11.3%
2015-07-31 23:49 2013-11-01 Lambert Henry R. Director, Officer - Chief Executive Officer BUY $0.70 42,857 $30,000 542,857 +8.6%
2014-08-06 01:46 2014-08-01 Otis William Director BUY $0.85 20,000 $17,000 220,000 +10.0%
2014-07-22 02:09 2014-07-18 THENO DAVID M Director BUY $0.85 30,000 $25,500 230,000 +15.0%
2014-07-04 01:25 2014-07-02 Pfanzelter David J Director BUY $0.85 35,294 $30,000 2,835,294 +1.3%
2013-11-06 02:26 2013-11-01 Lambert Henry R. Director, Officer - Chief Executive Officer BUY $0.75 40,000 $30,000 540,000 +8.0%
2011-07-01 23:10 2011-06-29 BARNHILL GREGORY HURD Director BUY $0.78 50,000 $38,765 704,589 +7.6%
2011-06-23 01:04 2011-06-21 BARNHILL GREGORY HURD Director BUY $0.89 25,000 $22,345 654,589 +4.0%
2011-01-29 00:40 2011-01-26 Carbone John J Director BUY $2.06 25,000 $51,500 97,750 +34.4%
2010-12-04 00:30 2010-12-01 BROVARONE DENNIS Director OPT+S $2.15 10,000 $21,479 255,141 0.0%
2010-11-05 01:43 2010-11-03 SINGER DONNA Director, Officer - Vice President/Asst Secretary OPT+S $2.35 30,000 $70,464 372,755 0.0%
2010-11-05 01:42 2010-11-02 BROVARONE DENNIS Director OPT+S $2.47 19,700 $48,618 255,141 0.0%
2010-11-02 01:28 2010-10-28 BROVARONE DENNIS Director OPT+S $2.82 30,300 $85,391 255,141 0.0%
2010-10-09 00:52 2010-10-06 SINGER DONNA Director, Officer - Vice President/Asst Secretary OPT+S $2.38 60,000 $142,800 372,755 0.0%
2010-10-06 03:01 2010-10-01 BROVARONE DENNIS Director OPT+S $2.35 30,000 $70,596 255,141 0.0%
2010-09-14 02:15 2010-09-09 BROVARONE DENNIS Director OPT+S $2.05 30,000 $61,485 255,141 0.0%
2010-08-14 01:02 2010-08-11 BROVARONE DENNIS Director OPT+S $2.30 30,000 $68,850 255,141 0.0%
2010-08-07 01:06 2010-08-04 SINGER DONNA Director, Officer - Vice President/Asst Secretary OPT+S $2.62 30,000 $78,600 372,755 0.0%
2010-07-16 02:01 2010-07-13 BROVARONE DENNIS Director SELL $2.08 20,000 $41,600 255,141 -7.3%
2010-07-10 02:46 2010-07-07 BARNHILL GREGORY HURD Director BUY $1.84 5,000 $9,200 558,044 +0.9%
2010-07-10 02:44 2010-07-07 SINGER DONNA Director, Officer - Vice President/Asst Secretary OPT+S $2.17 30,000 $64,980 372,755 0.0%
2010-07-01 01:30 2010-06-28 Buckland Andrew J Officer - Chief Financial Officer OPT+S $2.67 100,000 $267,230 47,609 0.0%
2010-04-16 23:16 2010-04-14 BARNHILL GREGORY HURD Director BUY $2.72 5,000 $13,600 540,044 +0.9%
2010-04-08 04:42 2010-04-06 BARNHILL GREGORY HURD Director BUY $2.02 10,000 $20,156 535,044 +1.9%
2010-03-16 03:42 2010-03-15 BARNHILL GREGORY HURD Director BUY $1.80 10,000 $18,000 525,044 +1.9%
SHOW ENTRIES

How to Interpret $PURE Trades

Not every insider transaction in PURE BIOSCIENCE, INC. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $PURE shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for PURE

Insider activity data for PURE BIOSCIENCE, INC. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $PURE, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.